Results     22-May-18
Announcements
Astrazeneca Pharma India reports standalone net profit of Rs 3.22 crore in the March 2018 quarter
Sales rise 30.27% to Rs 150.73 crore
Net profit of Astrazeneca Pharma India reported to Rs 3.22 crore in the quarter ended March 2018 as against net loss of Rs 9.56 crore during the previous quarter ended March 2017. Sales rose 30.27% to Rs 150.73 crore in the quarter ended March 2018 as against Rs 115.71 crore during the previous quarter ended March 2017.

For the full year,net profit rose 29.23% to Rs 25.91 crore in the year ended March 2018 as against Rs 20.05 crore during the previous year ended March 2017. Sales rose 5.02% to Rs 571.00 crore in the year ended March 2018 as against Rs 543.70 crore during the previous year ended March 2017.

ParticularsQuarter EndedYear Ended
 Mar. 2018Mar. 2017% Var.Mar. 2018Mar. 2017% Var.
Sales150.73115.71 30 571.00543.70 5
OPM %10.130.60 -8.116.79 -
PBDT17.611.69 942 58.5451.33 14
PBT14.06-1.99 LP 43.8035.50 23
NP3.22-9.56 LP 25.9120.05 29

Previous News
  AstraZeneca Pharma receives DCGI approves to import pharmaceutical formulation for Dapagliflozin Tablets
 ( Corporate News - 24-Jul-23   18:05 )
  Volumes spurt at Astrazeneca Pharma India Ltd counter
 ( Hot Pursuit - 24-Sep-24   14:30 )
  Nifty above 22,950; European mkt opens lower
 ( Market Commentary - Mid-Session 28-May-24   13:43 )
  Astrazeneca Pharma gets nod from CDSCO to import Olaparib film coated tablets
 ( Hot Pursuit - 22-Nov-23   11:07 )
  Astrazeneca Pharma India standalone net profit rises 184.76% in the March 2021 quarter
 ( Results - Announcements 25-May-21   17:28 )
  Astrazenenca Pharma gets CDSCO nod to import Durvalumab solutions
 ( Hot Pursuit - 24-Sep-24   08:54 )
  Astrazeneca Pharma India standalone net profit rises 96.78% in the June 2022 quarter
 ( Results - Announcements 08-Aug-22   14:55 )
  Astrazeneca Pharma India Ltd leads gainers in 'A' group
 ( Hot Pursuit - 24-Sep-24   12:00 )
  Board of Astrazeneca Pharma India recommends final dividend
 ( Corporate News - 31-May-23   12:56 )
  Astrazeneca Pharma India receives DCGI approval to import, market Selumetinib capsules
 ( Hot Pursuit - 27-Sep-21   09:37 )
  Astrazeneca Pharma India standalone net profit rises 172.47% in the September 2022 quarter
 ( Results - Announcements 11-Nov-22   17:08 )
Other Stories
  Shri Bholanath Carpets reports standalone net profit of Rs 0.02 crore in the June 2024 quarter
  30-Sep-24   07:34
  Gala Precision Engineering consolidated net profit rises 38.55% in the June 2024 quarter
  30-Sep-24   07:34
  Kross standalone net profit declines 4.25% in the June 2024 quarter
  28-Sep-24   07:36
  Jamna Auto Industries consolidated net profit rises 1.73% in the June 2024 quarter
  28-Sep-24   07:35
  Baazar Style Retail reports standalone net loss of Rs 0.39 crore in the June 2024 quarter
  26-Sep-24   07:35
  Mysore Paper Mills reports standalone net loss of Rs 22.19 crore in the June 2024 quarter
  26-Sep-24   07:35
  Educomp Solutions reports standalone net loss of Rs 1.81 crore in the June 2024 quarter
  25-Sep-24   07:30
  Ecos (India) Mobility & Hospitality consolidated net profit declines 3.08% in the June 2024 quarter
  25-Sep-24   07:30
  Orissa Minerals Development Company reports standalone net loss of Rs 2.08 crore in the June 2024 quarter
  24-Sep-24   07:43
  Apis India consolidated net profit declines 40.92% in the June 2024 quarter
  21-Sep-24   07:30
Back Top